4-Hydroxyphenylboronic Acid CAS 71597-85-8 - Manufacturers, Suppliers, Factory from China

4-Hydroxyphenylboronic Acid CAS 71597-85-8, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

4-Hydroxyphenylboronic Acid Pinacol Ester CAS 269409-70-3 Purity >98.0% (GC) Factory High Quality

DL-2,3-Diaminopropionic Acid Hydrochloride CAS 54897-59-5 Assay 98.5-101.5% (Titration) Purity ≥99.0% (HPLC)

2,3-Diaminopropionic Acid CAS 515-94-6 Assay ≥98.0% (Titration)

DL-2,3-Diaminopropionic Acid Hydrobromide CAS 18635-45-5 Assay ≥98.0% (Titration)

DL-2-Aminobutyric Acid CAS 2835-81-6 Assay ≥99.0% (Titration)

DL-Homocysteic Acid CAS 504-33-6 Assay ≥98.0% (TLC)

Top Selling Products

Related Blog
Reviews

Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.12.18 13:24:44
2022.12.13 02:56:31
2022.12.03 17:08:44
2022.04.18 13:06:29
2022.03.15 13:58:34
2022.01.04 18:55:17

4-Hydroxyphenylboronic Acid CAS 71597-85-8 - Manufacturers, Suppliers, Factory from China

Related Products

4-Hydroxyphenylboronic Acid CAS 71597-85-8 Purity >99.5% (HPLC) Factory High Quality

4-Hydroxyphenylboronic Acid Pinacol Ester CAS 269409-70-3 Purity >98.0% (GC) Factory High Quality

DL-2,3-Diaminopropionic Acid Hydrochloride CAS 54897-59-5 Assay 98.5-101.5% (Titration) Purity ≥99.0% (HPLC)

2,3-Diaminopropionic Acid CAS 515-94-6 Assay ≥98.0% (Titration)

DL-2,3-Diaminopropionic Acid Hydrobromide CAS 18635-45-5 Assay ≥98.0% (Titration)

DL-2-Aminobutyric Acid CAS 2835-81-6 Assay ≥99.0% (Titration)

DL-Homocysteic Acid CAS 504-33-6 Assay ≥98.0% (TLC)

Top Selling Products

3-Isopropoxybenzoic Acid CAS 60772-67-0

2,6-Dibromo-3-Nitropyridine CAS 55304-80-8 Purity ≥98.0% (HPLC) Factory

1,2-O-Isopropylidene-α-D-Xylofuranose CAS 20031-21-4 Assay >98.0% (TLC)

3-Aminobenzoic Acid CAS 99-05-8 Factory High Quality

(R)-(-)-1-Aminoindane CAS 10277-74-4 Purity >98.0% (GC) E.E >98.0%

2-Bromo-5-Nitrothiazole CAS 3034-48-8 Purity >98.0% (GC) Manufacturer

Boc-D-Arg(Tos)-OH CAS 61315-61-5 Purity >98.0% (HPLC)

2,3-Difluoropyridine CAS 1513-66-2 Purity >98.0% (GC) Factory High Quality

Tenofovir CAS 147127-20-6 Assay 98.0%~102.0% API Anti-HIV Factory

TAPS Sodium Salt CAS 91000-53-2 Purity >99.0% (Titration) Biological Buffer Factory

D-Threoninol (H-D-Thr-ol) CAS 44520-55-0 Assay ≥97.0% (NMR)

Tolvaptan CAS 150683-30-0 API Purity >99.0% (HPLC)

Method Of Analyzing Palladium Content In Palladium Catalysts

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Xi presents award to top scientists

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

New COVID treatments offer hope

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

2022.12.18 13:24:44

2022.12.13 02:56:31

2022.12.03 17:08:44

2022.04.18 13:06:29

2022.03.15 13:58:34

2022.01.04 18:55:17

related search